Information Provided By: 
Fly News Breaks for February 24, 2020
IMVT, DNLI, ALT, CVNA, LEVI
Feb 24, 2020 | 10:21 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Levi Strauss (LEVI) initiated with a Buy at UBS. 2. Carvana (CVNA) initiated with a Hold at Deutsche Bank. 3. Altimmune (ALT) resumed with a Buy at Roth Capital. 4. Denali Therapeutics (DNLI) initiated with a Buy at Jefferies. 5. Immunovant (IMVT) initiated with an Outperform at SVB Leerink. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For LEVI;CVNA;ALT;DNLI;IMVT From the Last 2 Days
CVNA
Apr 25, 2024 | 08:27 EDT
CVNA
Apr 24, 2024 | 08:00 EDT
Jefferies lowered the firm's price target on Carvana to $80 from $85 and keeps a Hold rating on the shares. The firm expects "another solid EBITDA print" as Carvana prioritizes unit economics over unit growth, the analyst tells investors in a preview note for the U.S. Internet group.
